Publication | Closed Access

Neoadjuvant chemotherapy with paclitaxel and everolimus in breast cancer patients with non-responsive tumours to epirubicin/cyclophosphamide (EC)±bevacizumab – Results of the randomised GeparQuinto study (GBG 44)

Breast OncologyGbg 44Breast Cancer PatientsMedicineCancer ManagementPharmacologyBreast CancerPharmacotherapyCancer TreatmentOncologyCancer ResearchNeoadjuvant Chemotherapy